1236001-15-2

Basic information

• Product Name: 2-(5-bromopyridin-2-yl)-2,2-difluoroethanol
• CAS NO: 1236001-15-2
• Molecular Weight: 238.032
• Mol File: 1236001-15-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(5-bromopyridin-2-yl)-2,2-difluoroethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(5-bromopyridin-2-yl)-2,2-difluoroethanol(1236001-15-2)
• EPA Substance Registry System: 2-(5-bromopyridin-2-yl)-2,2-difluoroethanol(1236001-15-2)

Safety Data

• Hazardous Substances Data: 1236001-15-2(Hazardous Substances Data)

Usage

General Description

2-(5-bromopyridin-2-yl)-2,2-difluoroethanol is a chemical compound with the molecular formula C7H6BrF2NO. It is a white crystalline solid that is commonly used in organic synthesis and medicinal chemistry. 2-(5-bromopyridin-2-yl)-2,2-difluoroethanol is known for its potent antifungal and antibacterial properties, making it a valuable ingredient in pharmaceuticals and agricultural products. It is also used as a building block in the synthesis of various compounds and drug intermediates. Additionally, 2-(5-bromopyridin-2-yl)-2,2-difluoroethanol has been studied for its potential applications in the development of new drugs and materials.

Upstream product

• 294181-95-6 2-(5-bromopyridine-2-yl)-2,2-difluoroacetic acid ethyl ester 

Relevant articles and documents

1,4-THIAZINE DIOXIDE AND 1,2,4-THIADIAZINE DIOXIDE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE

The present disclosure provides a class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula I: wherein variables A, X, R2, R2', R3, R4, R5, R6, and R7 of Formula I are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, and uses of the compounds and compositions for treatment of disorders and/or conditions related to Aβ plaque formation and deposition, resulting from the biological activity of BACE. Such BACE mediated disorders include, for example, Alzheimer's Disease, cognitive deficits, cognitive impairments, and other central nervous system conditions.

OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION

This invention relates to potent potassium channel blocker compounds of structural Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.